Overview
Dr. Krishna Udayakumar is the founding Director of the Duke Global Health Innovation Center, focused on generating deeper evidence and support for the study, scaling, and adaptation of health innovations and policy reforms globally. He is also Executive Director of Innovations in Healthcare, a non-profit co-founded by Duke, McKinsey & Company, and the World Economic Forum to curate and scale the impact of transformative health solutions globally.
At Duke University, Dr. Udayakumar holds the rank of Professor of Global Health along with a secondary faculty appointment in Medicine. He is a core faculty member of the Duke-Margolis Institute for Health Policy. His work has been published in leading academic journals such as the New England Journal of Medicine, Health Affairs, and Academic Medicine.
Born in Bangalore, India, Dr. Udayakumar spent his childhood in Virginia, and is a Phi Beta Kappa graduate of the University of Virginia, with a bachelor’s degree in interdisciplinary studies with distinction. He received both an MD and an MBA (with a concentration in Health Sector Management) from Duke University, where he was a Fuqua Scholar. Dr. Udayakumar completed his residency training in internal medicine at Duke and served as Assistant Chief Resident at the Durham VA Medical Center before joining the faculty of Duke University.Current Appointments & Affiliations
Recent Publications
The New U.S. Global Health Strategy - A Reset of America's Health Cooperation.
Journal Article N Engl J Med · December 4, 2025 Full text Link to item CiteRapid establishment of public sector COVID-19 test-and-treatment programmes across seven low- and middle-income countries: implementation strategies and program monitoring results.
Journal Article BMJ global health · December 2025 The COVID-19 Treatment QuickStart Consortium worked with governments in seven low- and middle-income countries (LMICs), Ghana, Laos, Malawi, Nigeria, Rwanda, Uganda and Zambia, to implement COVID-19 test-and-treat programmes at 776 health facilities, inclu ... Full text CiteMixed methods implementation research of oral antiviral treatment for COVID-19 in low- and middle-income countries: a study protocol.
Journal Article BMJ Open · September 18, 2025 INTRODUCTION: There is an absence of real-world evidence, especially from low- and middle-income countries (LMICs), on the implementation successes and challenges of COVID-19 Test and Treat (T&T) programmes. In 2022, nirmatrelvir/ritonavir was provided as ... Full text Open Access Link to item CiteRecent Grants
Accelerating multi-product introduction through advocacy and learning
ResearchPrincipal Investigator · Awarded by Bill and Melinda Gates Foundation · 2024 - 2028Health Trust Initiative
ResearchPrincipal Investigator · Awarded by Robert Wood Johnson Foundation · 2024 - 2025PIPP Phase I
ResearchAdvisor · Awarded by National Science Foundation · 2022 - 2025View All Grants